Citius Oncology, Inc. Share Price & Technical Analysis
CTOR · $0.84 (+1.20%)
Healthcare / Drug Manufacturers - Specialty & Generic
$0.84
+1.20%
Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. is a subsidiar…
Price chart
Seasonality
May has 2 positive and 1 negative years (last 5 years shown)
-11% return in May, 5% avg return in past 3 year May month.
13% return in 2026, 50% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 10% | 10% | -45% | 50% | -11% | – | – | – | – | – | – | – | 13% |
| 25 | 0% | 0% | -18% | 13% | 13% | 378% | -50% | 0% | -5% | -10% | -18% | -33% | 269% |
| 24 | 0% | 1% | 1% | 0% | 3% | 0% | -5% | -83% | -22% | -14% | -25% | 22% | -124% |
| 23 | 0% | 1% | -2% | 1% | 0% | 1% | 1% | 1% | 1% | 1% | 0% | 0% | 5% |
| 22 | – | – | – | – | – | – | – | – | – | – | – | 1% | 1% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. is a subsidiary of Leonard-Meron Biosciences, Inc.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$78.47M
P/E ratio
—
52W high
$6.19
52W low
$0.49
Volume
48,230
Beta
3.57
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Citius Oncology, Inc. share price today?
- Citius Oncology, Inc. (CTOR) last traded around $0.84 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CTOR have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CTOR. Download the app for real-time alerts.
- How can I analyze Citius Oncology, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.